Spreadsheet: 283c2935-78f4-411c-ab5e-108f8228f7a8
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
IGFG | Test | IGFG | Insulin-Like Growth Factor 1 (IGF-1) and Insulin-Like Growth Factor Binding Protein 3 (IGFBP-3) Growth Panel | IGF-1 and IGFBP-3 Growth Panel | IGF1I/35099: Chemiluminescence IGFB3/83300: Enzyme-Labeled Chemiluminescent Immunometric Assay | Plain, Red-Top Tube: Red Serum Gel Tube: SGT |  |  | 1 | mL | Collection Container/Tube: Preferred: Red top Acceptable: Serum gel Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: Spin down promptly. Aliquot into 2 equal portions. Additional Information: Indicate patient's age and sex. | 0.5mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK  Lipemia	Mild OK; [NAME] OK Icterus	NA Other	NA | INSULIN-LIKE GROWTH FACTOR 1 Males: Age	ng/mL	0.1 Percentile (ng/mL) 0-11 months	15-150	3 1 year	18-179	4 2 years	22-204	5 3 years	25-224	6 4 years	28-241	8 5 years	32-259	9 6 years	36-281	11 7 years	42-311	13 8 years	49-351	16 9 years	58-401	19 10 years	70-458	24 11 years	82-516	29 12 years	93-567	35 13 years	103-603	41 14 years	111-620	46 15 years	115-618	50 16 years	115-598	52 17 years	113-566	54 18 years	109-527	  19 years	104-484	  20 years	98-443	  21-25 years	83-344	  26-30 years	75-275	  31-35 years	71-241	  36-40 years	69-226	  41-45 years	64-210	  46-50 years	59-201	  51-55 years	56-201	  56-60 years	51-194	  61-65 years	47-191	  66-70 years	46-195	  71-75 years	42-187	  76-80 years	39-184	  80-85 years	37-182	  85-90 years	35-182	    Females: Age	ng/mL	0.1 Percentile (ng/mL) 0-11 months	18-146	5 1 year	20-159	6 2 years	23-177	7 3 years	27-198	8 4 years	32-223	10 5 years	36-246	12 6 years	41-269	15 7 years	48-299	17 8 years	56-339	21 9 years	68-396	26 10 years	83-465	32 11 years	99-537	40 12 years	115-598	48 13 years	126-637	56 14 years	133-647	62 15 years	134-631	65 16 years	130-595	66 17 years	123-546	64 18 years	114-493	  19 years	105-441	  20 years	97-398	  21-25 years	84-323	  26-30 years	77-271	  31-35 years	73-244	  36-40 years	68-225	  41-45 years	62-205	  46-50 years	56-194	  51-55 years	53-191	  56-60 years	45-173	  61-65 years	41-168	  66-70 years	39-168	  71-75 years	36-166	  76-80 years	35-168	  80-85 years	35-179	  85-90 years	33-179	  Reference values have not been established for patients that are >90 years of age.   IGF-1 reference values according to Tanner stages I-V(2) Males  Stage I: 83-255 ng/mL Stage II: 114-440 ng/mL Stage III: 236-516 ng/mL Stage IV: 218-580 ng/mL Stage V: 229-522 ng/mL Females Stage I: 90-324 ng/mL  Stage II: 104-456 ng/mL Stage III: 249-519 ng/mL Stage IV: 238-574 ng/mL Stage V: 187-509 ng/mL   Note: Puberty onset, ie the transition from Tanner stage 1 (prepubertal) to Tanner stage 2 (early pubertal), occurs for girls at a median age of 10.5 (+/-2) years and for boys at a median age of 11.5 (+/-2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African-American girls. By contrast, for boys there is no definite proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage 5 (young adult) should be reached by age 18.   INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 1-7 days: < or =0.7 mcg/mL 8-14 days: 0.5-1.4 mcg/mL 15 days-11 months: unavailable 1 year: 0.7-3.6 mcg/mL 2 years: 0.8-3.9 mcg/mL 3 years: 0.9-4.3 mcg/mL 4 years: 1.0-4.7 mcg/mL 5 years: 1.1-5.2 mcg/mL  6 years: 1.3-5.6 mcg/mL 7 years: 1.4-6.1 mcg/mL 8 years: 1.6-6.5 mcg/mL 9 years: 1.8-7.1 mcg/mL 10 years: 2.1-7.7 mcg/mL 11 years: 2.4-8.4 mcg/mL 12 years: 2.7-8.9 mcg/mL 13 years: 3.1-9.5 mcg/mL 14 years: 3.3-10 mcg/mL 15 years: 3.5-10 mcg/mL 16 years: 3.4-9.5 mcg/mL 17 years: 3.2-8.7 mcg/mL 18 years: 3.1-7.9 mcg/mL 19 years: 2.9-7.3 mcg/mL 20 years: 2.9-7.2 mcg/mL 21-25 years: 3.4-7.8 mcg/mL 26-30 years: 3.5-7.6 mcg/mL 31-35 years: 3.5-7.0 mcg/mL 36-40 years: 3.4-6.7 mcg/mL 41-45 years: 3.3-6.6 mcg/mL 46-50 years: 3.3-6.7 mcg/mL 51-55 years: 3.4-6.8 mcg/mL 56-60 years: 3.4-6.9 mcg/mL 61-65 years: 3.2-6.6 mcg/mL 66-70 years: 3.0-6.2 mcg/mL 71-75 years: 2.8-5.7 mcg/mL 76-80 years: 2.5-5.1 mcg/mL 81-85 years: 2.2-4.5 mcg/mL   Tanner Stages: Males Stage I: 1.2-6.4 mcg/mL  Stage II: 2.8-6.9 mcg/mL Stage III: 3.9-9.4 mcg/mL Stage IV: 3.3-8.1 mcg/mL Stage V: 2.7-9.1 mcg/mL Females Stage I: 1.4-5.2 mcg/mL Stage II: 2.3-6.3 mcg/mL Stage III: 3.1-8.9 mcg/mL Stage IV: 3.7-8.7 mcg/mL Stage V: 2.6-8.6 mcg/mL   Note: Puberty onset, ie the transition from Tanner stage 1 (prepubertal) to Tanner stage 2 (early pubertal), occurs for girls at a median age of 10.5 (+/-2) years and for boys at a median age of 11.5 (+/-2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African-American girls. By contrast, for boys there is no definite proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage 5 (young adult) should be reached by age 18. | Monday through Friday 5 a.m. - 12 a.m., Saturday 6 a.m. - 6 p.m. | Same day/1 day | 3 days |  | Profile |  |  |  |  | Rochester
IGFG | [NAME] | SERUM | Serum |  |  |  | Frozen | 14 days
IGFG | Component | IGF1I | Insulin-Like Growth Factor 1, Serum | Insulin-Like Growth Factor 1, S | Chemiluminescence | Serum Gel Tube: SGT |  |  | 0.5 | mL | Collection Container/Tube: Preferred: Red top Acceptable: Serum gel Submission Container/Tube: Plastic vial [NAME]: 0.5 mL Collection Instructions: Spin down promptly. Additional Information: Indicate patient's age and sex. Forms: If not ordering electronically, submit a General Request Form (Supply T239) with the specimen. | 0.25 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK  Lipemia	Mild OK; [NAME] OK Icterus	NA Other	NA | Males: Age	ng/mL	0.1 Percentile (ng/mL) 0-11 months	15-150	3 1 year	18-179	4 2 years	22-204	5 3 years	25-224	6 4 years	28-241	8 5 years	32-259	9 6 years	36-281	11 7 years	42-311	13 8 years	49-351	16 9 years	58-401	19 10 years	70-458	24 11 years	82-516	29 12 years	93-567	35 13 years	103-603	41 14 years	111-620	46 15 years	115-618	50 16 years	115-598	52 17 years	113-566	54 18 years	109-527	  19 years	104-484	  20 years	98-443	  21-25 years	83-344	  26-30 years	75-275	  31-35 years	71-241	  36-40 years	69-226	  41-45 years	64-210	  46-50 years	59-201	  51-55 years	56-201	  56-60 years	51-194	  61-65 years	47-191	  66-70 years	46-195	  71-75 years	42-187	  76-80 years	39-184	  80-85 years	37-182	  85-90 years	35-182	    Females: Age	ng/mL	0.1 Percentile (ng/mL) 0-11 months	18-146	5 1 year	20-159	6 2 years	23-177	7 3 years	27-198	8 4 years	32-223	10 5 years	36-246	12 6 years	41-269	15 7 years	48-299	17 8 years	56-339	21 9 years	68-396	26 10 years	83-465	32 11 years	99-537	40 12 years	115-598	48 13 years	126-637	56 14 years	133-647	62 15 years	134-631	65 16 years	130-595	66 17 years	123-546	64 18 years	114-493	  19 years	105-441	  20 years	97-398	  21-25 years	84-323	  26-30 years	77-271	  31-35 years	73-244	  36-40 years	68-225	  41-45 years	62-205	  46-50 years	56-194	  51-55 years	53-191	  56-60 years	45-173	  61-65 years	41-168	  66-70 years	39-168	  71-75 years	36-166	  76-80 years	35-168	  80-85 years	35-179	  85-90 years	33-179	  Reference values have not been established for patients that are >90 years of age.   IGF-1 reference values according to Tanner stages I-V(2) Males Stage I: 83-255 ng/mL Stage II: 114-440 ng/mL Stage III: 236-516 ng/mL Stage IV: 218-580 ng/mL Stage V: 229-522 ng/mL Females Stage I: 90-324 ng/mL Stage II: 104-456 ng/mL Stage III: 249-519 ng/mL Stage IV: 238-574 ng/mL Stage V: 187-509 ng/mL   Note: Puberty onset, ie the transition from Tanner stage 1 (prepubertal) to Tanner stage 2 (early pubertal), occurs for girls at a median age of 10.5 (+/-2) years and for boys at a median age of 11.5 (+/-2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African-American girls. By contrast, for boys there is no definite proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage 5 (young adult) should be reached by age 18. | Monday through Friday; 5 a.m.-12a.m., Saturday; 6 a.m.-6 p.m. | Same day/1 day | 3 days | 1 | 84305 |  |  | Yes | Yes
IGF1I | [NAME] | SERUM | Serum |  |  |  | Frozen | 14 days
IGF1I | Result | IGF1I | Insulin-Like Growth Factor 1, S | Insulin-Like Growth Factor 1, S | Numeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 2484-4
IGFG | Component | IGFB3 | Insulin-Like Growth Factor Binding Protein 3 (IGFBP-3), Serum | IGFBP-3, S | Enzyme-Labeled Chemiluminescent Immunometric Assay | Serum Gel Tube: SGT |  |  | 0.8 | mL | Container/Tube: Preferred: Red top Acceptable: Serum gel [NAME]: 0.8 mL Collection Instructions: Spin down promptly. Additional Information: Indicate patient's age and sex. Forms: If not ordering electronically, submit a General Request Form (Supply T239) with the specimen. | 0.3 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK  Lipemia	Mild OK; [NAME] OK Icterus	NA Other	NA | 1-7 days: < or =0.7 mcg/mL 8-14 days: 0.5-1.4 mcg/mL 15 days-11 months: unavailable 1 year: 0.7-3.6 mcg/mL 2 years: 0.8-3.9 mcg/mL 3 years: 0.9-4.3 mcg/mL 4 years: 1.0-4.7 mcg/mL 5 years: 1.1-5.2 mcg/mL  6 years: 1.3-5.6 mcg/mL 7 years: 1.4-6.1 mcg/mL 8 years: 1.6-6.5 mcg/mL 9 years: 1.8-7.1 mcg/mL 10 years: 2.1-7.7 mcg/mL 11 years: 2.4-8.4 mcg/mL 12 years: 2.7-8.9 mcg/mL 13 years: 3.1-9.5 mcg/mL 14 years: 3.3-10 mcg/mL 15 years: 3.5-10 mcg/mL 16 years: 3.4-9.5 mcg/mL 17 years: 3.2-8.7 mcg/mL 18 years: 3.1-7.9 mcg/mL 19 years: 2.9-7.3 mcg/mL 20 years: 2.9-7.2 mcg/mL 21-25 years: 3.4-7.8 mcg/mL 26-30 years: 3.5-7.6 mcg/mL 31-35 years: 3.5-7.0 mcg/mL 36-40 years: 3.4-6.7 mcg/mL 41-45 years: 3.3-6.6 mcg/mL 46-50 years: 3.3-6.7 mcg/mL 51-55 years: 3.4-6.8 mcg/mL 56-60 years: 3.4-6.9 mcg/mL 61-65 years: 3.2-6.6 mcg/mL 66-70 years: 3.0-6.2 mcg/mL 71-75 years: 2.8-5.7 mcg/mL 76-80 years: 2.5-5.1 mcg/mL 81-85 years: 2.2-4.5 mcg/mL   Tanner Stages: Males Stage I: 1.2-6.4 mcg/mL Stage II: 2.8-6.9 mcg/mL Stage III: 3.9-9.4 mcg/mL Stage IV: 3.3-8.1 mcg/mL Stage V: 2.7-9.1 mcg/mL Females Stage I: 1.4-5.2 mcg/mL Stage II: 2.3-6.3 mcg/mL Stage III: 3.1-8.9 mcg/mL Stage IV: 3.7-8.7 mcg/mL Stage V: 2.6-8.6 mcg/mL   Note: Puberty onset, ie, the transition from Tanner stage I (prepubertal) to Tanner stage II (early pubertal), occurs for girls at a median age of 10.5 (+/-2) years and for boys at a median age of 11.5 (+/-2) years. There is evidence that it may occur up to 1 year earlier in obese girls and in African-American girls. By contrast, for boys there is no definite proven relationship between puberty onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage V (young adult) should be reached by age 18. | Monday through Friday 5 a.m.-12 a.m., Saturday 6 a.m. - 6p.m. | Same day/1 day | 3 days | 1 | 83520 |  |  | Yes | Yes
IGFB3 | [NAME] | SERUM | Serum |  |  |  | Frozen | 14 days
IGFB3 | Result | IGFB3 | IGFBP-3, S | IGFBP-3, S | Numeric |  |  |  |  | mcg/mL |  |  |  |  |  |  |  |  |  | 2483-6